Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rivastigmine for unilateral spatial neglect after right-hemisphere stroke
2004-000507-17Phase 2Active
- Sponsor
- Fondazione Santa Lucia IRCCS
- Start
- May 2005
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Reversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of rivastigmine in hemispatial neglect and stroke, sponsored by Fondazione Santa Lucia IRCCS. Started May 2005; status: active.
02
Drugs
rivastigmine
03
Conditions
hemispatial neglectstroke
Beyond the preview
Go deeper on 2004-000507-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-000507-17.